IDiyas

For the Inventor, By the Inventor

Medford, MA, United States of America

Kristopher N Hahn

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 13.6

ph-index = 4

Forward Citations = 38(Granted Patents)


Company Filing History:

goldMedal14 out of 15 
 
Morphic Therapeutic, Inc.
 patents

Years Active: 2020-2025

Loading Chart...
Loading Chart...
14 patents (USPTO):
1. 12459942 - Inhibiting (α-v)(β-6) integrin (2025-11-04),
2. 12415796 - Inhibitors of (αv)(β6) integrin (2025-09-16),
3. 12221416 - Antagonists of human integrin α4β7 (2025-02-11),
4. 12145935 - Inhibitors of (α-v)(β-6) integrin (2024-11-19),
5. 11827621 - Inhibitors of (α-v)(β-6) integrin (2023-11-28),
6. 11795167 - Inhibitors of (α-v)(β-6) integrin (2023-10-24),
7. 11739087 - Inhibiting (α-v)(β-6) integrin (2023-08-29),
8. 11370773 - Inhibiting human integrin (alpha-4) (beta-7) (2022-06-28),
9. 11174228 - Antagonists of human integrin (α4)(β7) (2021-11-16),
10. 11104661 - Inhibiting human integrin (α-4) (β-7) (2021-08-31),
11. 11046685 - Inhibitors of (α-v)(β-6) integrin (2021-06-29),
12. 11046669 - Inhibitors of (α-v)(β-6) integrin (2021-06-29),
13. 11040955 - Inhibitors of (alpha-v)(beta-6) integrin (2021-06-22),
14. 10759756 - Antagonists of human integrin α4β7 (2020-09-01),

Title: Innovations and Contributions of Kristopher N Hahn

Introduction

Kristopher N Hahn is a prominent inventor based in Medford, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of small molecule inhibitors and antagonists targeting specific integrins. With a total of 13 patents to his name, Hahn's work has the potential to impact the treatment of various diseases and conditions.

Latest Patents

Hahn's latest patents include innovative compounds such as inhibitors of αvβ6 integrin. These small molecule inhibitors are designed to treat a range of diseases and conditions by targeting this specific integrin. Additionally, he has developed antagonists of human integrin α4β7, which are also small molecules aimed at treating specific diseases or conditions.

Career Highlights

Kristopher N Hahn is currently associated with Morphic Therapeutics, Inc., where he continues to advance his research and development efforts. His work at Morphic Therapeutics focuses on creating novel therapeutic solutions that leverage his expertise in integrin biology.

Collaborations

Hahn collaborates with talented individuals in his field, including colleagues such as Bryce Alden Harrison and Matthew Gregory Bursavich. These collaborations enhance the innovative potential of his research and contribute to the success of their projects.

Conclusion

Kristopher N Hahn's contributions to the field of biomedical research through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for new therapeutic approaches in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…